Optimum Ribavirin Exposure Overcomes Racial Disparity in Efficacy of Peginterferon and Ribavirin Treatment for Hepatitis C Genotype 1
American Journal of Gastroenterology - United States
doi 10.1038/ajg.2012.306
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)